PR Log - Global Press Release Distribution

Indian Pharma Sector Analysis

By Bharat Book Bureau

Dated: Jan 12, 2008

The market research report “Indian Pharma Sector Analysis”, detailed study of the Indian pharmaceutical
market.

The market research report “Indian Pharma Sector Analysis”, detailed study of the Indian pharmaceutical
market. It does an exhaustive investigation on the structure of the domestic pharmaceutical market and
gives a thorough analysis of the driving and restraining forces operating against it.

India has one of the fastest growing pharmaceutical markets in the world. In 2006-07, this market was
valued at over US$ 7 Billion. Driven by a huge patient base, increasing incomes, improving healthcare
infrastructure and strong penetration of health insurance, the pharmaceutical market is expected to grow
more than double its size in the next five years. Drugs for acute diseases presently dominate this market;
however, the increasing penetration of lifestyle-related diseases is expected to fuel the growth of drugs
targeting chronic diseases.

The Indian pharmaceutical market at present is highly fragmented, with the top three companies having a
market share of around 5% each. However, introduction of the product patent regime is likely to result in
heavy consolidation in future.

Key Findings
The domestic pharmaceutical market in India has grown at a CAGR of nearly 12% in the last five years.
At present, drugs for mass therapies dominate, however, driven by an increasing prevalence of
lifestyle-associated diseases, drugs for specialty therapies are expected to remain buoyant in future.
Around 67 Million Indians are expected to be above 67 years of age by 2011. This age group spends
around 3 to 4 times more on drugs than those in younger age groups, thus fuelling the market growth.
Patented drugs, which had no share in the pharmaceutical market, are expected to have a 10% market share
in 2010.
Around 64% Indians are not covered under by health insurance and pay expenses for pharmaceuticals out
of pocket.
Driven by factors such as rising rural incomes and a strong distribution network, India’s rural
pharmaceutical market is experiencing a strong growth.
The product patent regime will encourage the Indian companies to invest more in Research and
Development.
Key Issues & Facts Analyzed
Evaluation of past, current and future market trends.
Evaluation of the market by segment.
Discussion about the major drivers of the pharmaceutical market.
Analysis of the opportunities created by the market.
Review on the government regulations on the market.
Analysis of the major challenges faced by the market.
Competitive landscape of the market.
Key Players Analyzed

This section provides the overview, key facts and financial information of prominent players in the Indian
pharmaceutical market Like Ranbaxy Laboratories Limited, Cipla Limited, GlaxoSmithKline
Pharmaceuticals Limited, Nicholas Piramal India Limited and Zydus Cadila.

Page 1/4
PR Log - Global Press Release Distribution

Research Methodology Used

Information Sources
Information has been sourced from books, newspapers, trade journals, and white papers, industry portals,
government agencies, trade associations, monitoring industry news and developments, and through access
to more than 3000 paid databases.

Analysis Methods
The analysis methods include ratio analysis, historical trend analysis, linear regression analysis using
software tools, judgmental forecasting, and cause and effect analysis.
Table of Contents
1. Analyst View
2. Global Pharmaceutical Market
2.1 Market Size & Growth
2.2 Leading Therapy Classes
2.3 Leading Pharmaceutical Companies
2.4 Leading Drugs
2.5 Geographical Performance
2.6 India - The Emerging Market
3. India - Macroecomomic & Healthcare Profile
3.1 Macroeconomic Profile
3.1.1 GDP
3.1.2 Consumer Price Index
3.1.3 Currency Fluctuation
3.1.4 Foreign Direct Investment
3.2 Population Profile
3.2.1 Population
3.2.2 Sex Ratio
3.2.3 Age Profile
3.3 Healthcare Profile
3.3.1 Healthcare Spending
3.3.2 Sources of Healthcare Payments
3.3.3 Doctors & Nurses
3.3.4 Hospitals & Clinics
3.3.5 Top Causes of Mortality
4. Indian Pharmaceutical Market
4.1 Turnover
4.2 Exports & Imports
4.2.1 Exports
4.2.2 Imports
4.3 Bulk Drugs & Formulations
5. Domestic Pharmaceutical Market
5.1 Drivers
5.1.1 Ageing Population
5.1.2 Increasing Income
5.1.3 Product Patent Regime
5.1.4 Improving Medical Infrastructure
5.1.5 Increasing Prevalence of Lifestyle-related Diseases
5.2 Market Size & Growth

Page 2/4
PR Log - Global Press Release Distribution

5.3 Market Segmentation

5.3.1 By Drugs
5.3.1.1 Traditional Branded Generics
5.3.1.2 Specialty Branded Generics
5.3.1.3 Generic Generics
5.3.1.4 Patented Drugs
5.3.2 By Therapeutics
5.3.2.1 Acute Segment
5.3.2.2 Chronic Segment
5.4 Government Regulations & Market Entry
5.4.1 Industrial & Manufacturing License
5.4.2 Patent Laws
5.4.3 Research & Development
5.4.4 Pricing
5.4.5 Market Entry
5.5 Opportunities
5.5.1 For the Industry
5.5.1.1 Biogenerics
5.5.1.2 Rural Markets
5.5.1.3 Cardiovascular Market
5.5.1.4 Diabetes Market
5.5.1.5 Asthma Market
5.5.1.6 Obesity Market
5.5.1.7 Oncology Market
5.5.1.8 HIV Market
5.5.2 By the Industry
5.5.2.1 Contract Manufacturing
5.5.2.2 Contract Research
5.5.2.3 Bioinformatics
5.5.2.4 Health Insurance
5.5.2.5 Drug Delivery & Packaging Industries
5.5.2.6 Pharmaceutical Retail Chains
5.6 Challenges
5.6.1 Lack of Innovation
5.6.2 Drug Price Controls & Low Margins
5.6.3 Low Per Capita Spending on Drugs
5.6.4 Multinationals Reluctant to Invest in India
5.6.5 Counterfeit Drugs
5.6.6 Low Government Financing
5.7 Future Outlook
5.7.1 Market Drivers & Restraints
5.7.2 Sales (2007-08 to 2011-12)
6. Competitive Landscape
6.1 Market Structure
6.2 Market Share of Key Players
6.3 Profile of Key Players
6.3.1 Ranbaxy Laboratories Limited
6.3.2 Cipla Limited
6.3.3 GlaxoSmithKline Pharmaceuticals Limited
6.3.4 Nicholas Piramal India Limited

Page 3/4
PR Log - Global Press Release Distribution

6.3.5 Zydus Cadil

List of Table
Table 2-1: Global - Leading Therapy Classes by Sale (in Billion US$), 2006
Table 2-2: Global - Leading Drugs by Sale (in Billion US$), 2006
Table 2-3: Global - Pharmaceutical Market by Region (in Billion US$), 2006
Table 4-1: India - Pharmaceutical Exports to Top Countries (in Million US$), 2003-2005
Table 4-2: India - Pharmaceutical Imports from Top Countries (in Million US$), 2003-2005
Table 5-1: India - Share of Drugs for Acute Disorders in Domestic Pharmaceutical Market (%), 2006
Table 5-2: India - Share of Drugs for Chronic Disorders in Domestic Pharmaceutical Market (%), 2006
Table 5-3: India - Launch of Patented Drugs by Product & Company
Table 5-4: India - Number of Drug Delivery Companies by Formulation Type (1999, 2003 & 2007E)
Table 5-5: India - Expansion Plans of Pharmacy Retail Chains
Table 5-6: India - Counterfeit Drugs in Domestic Pharmaceutical Market
Table 6-1: India - Performance of Top 20 Pharmaceutical Companies, 2005
Table 6-2: India - Performance of Top 20 Pharmaceutical Companies, 2006
Table 6-3: Ranbaxy Laboratories Limited - Key Financials (in Million INR), 2004-2006
Table 6-4: Cipla Limited - Key Financials (in Million INR), 2005-06 & 2006-07
Table 6-5: GlaxoSmithKline Pharmaceuticals Limited - Key Financials (in Million US$), 2005 & 2006
Table 6-6: Nicholas Piramal India Limited - Key Financials (in Million INR), 2005-06 & 2006-07
Table 6-7: Zydus Cadila - Key Financials (in Million INR), March 2004 to March 2006

For more information, please visit :

http://www.bharatbook.com/detail.asp?id=71121

###

bharatbook.com, a leading information aggregator, facilitates and supports the business information needs
for market research , corporate / strategic planning by providing the latest information in the form of
reports, journals, magazines and databases on varied industries like automotive, oil and gas, shipping,
textiles, pharmaceuticals, energy, banking, finance, insurance, risk management, country intelligence,
consumer & durable goods, chemical and more. With over 90,000 reports, you can get instant access and
insights on the studies in your areas of interest. Contact us at +91 22 27578668 / 27579438 or email
info@bharatbook.com or our website www.bharatbook.com

Category Pharma
Tags indian pharma sector analysis
Email Click to email author
Website http://www.bharatbook.com
Phone +912227578668
Fax +912227579131
Address 207 Hermes Atrium, Sector 11
CBD Belapur Navi Mumbai
City/Town Navi Mumbai
State/Province Maharashtra
Zip 400614
Country India

Page 4/4